In a previous study, the NFKBIA gene (encoding the NF-κB inhibitor IκBα) was found to be deleted in 10.8% of breast cancer cases, and NFKBIA deletions were shown to be significantly associated with TNBC (present in 32.8% of cases). Here, NFKBIA is linked to breast carcinoma.